Description
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Cas No. | 104180-18-9 |
|---|---|
| Purity | ≥95% |
| Formula | C27H43N3O5S |
| Formula Wt. | 565.74 |
| Synonym | Chemotactic peptide, N-Formyl-Met-Leu-Phe-Lys |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.
ITC, erysolin analog.
Aromatase inhibitor.
Purine derivative; CDK inhibitor.
CDK4/6 inhibitor.
NSAID; COX-1/2 inhibitor.
Recombinant HIV-1 multi-epitope chimeric antige...
Triadimefon metabolite; mutagen.
Xanthine derivative; PDE inhibitor.
NO donor; AR antagonist.
Recombinant HIV-1 glycoprotein antigen fragment...
Alkaloid found in Corydalis and Stephania; D1/2...
α1A-adrenergic antagonist.
Synthetic nitrile compound
Dihydrofolate reductase inhibitor.
Endogenous peptide, involved in vasoconstrictio...
Neuraminidase inhibitor.
CDK9 inhibitor.
Nucleoside (adenosine) analog; viral DNA polyme...
Folic acid derivative
Akt inhibitor.